CNTB Cash-Secured Put Strategy
CNTB (Connect Biopharma Holdings Limited), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials, targeting inflammatory allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Additionally, Connect Biopharma's pipeline includes CBP-307, a small molecule designed to modulate sphingosine 1-phosphate receptor 1. This receptor plays a crucial role in regulating T cell movement from lymph nodes into the bloodstream.
CNTB (Connect Biopharma Holdings Limited) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $146.7M, a beta of -0.22 versus the broader market, a 52-week range of 1.23-3.82, average daily share volume of 370K, a public-listing history dating back to 2021, approximately 64 full-time employees. These structural characteristics shape how CNTB stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.22 indicates CNTB has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a cash-secured put on CNTB?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
CNTB snapshot
As of August 14, 2026, spot at $2.57, ATM IV 225.00%, IV rank 68.54%, expected move 64.51%. The cash-secured put on CNTB below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this cash-secured put structure on CNTB specifically: CNTB IV at 225.00% is mid-range versus its 1-year history, so the credit collected on a CNTB cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 64.51% (roughly $1.66 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CNTB expiries trade a higher absolute premium for lower per-day decay. Position sizing on CNTB should anchor to the underlying notional of $2.57 per share and to the trader's directional view on CNTB stock.
CNTB cash-secured put setup
The CNTB cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CNTB at $2.57 on that close, the first option leg uses a $2.44 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CNTB chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CNTB shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $2.44 | N/A |
CNTB cash-secured put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
CNTB cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on CNTB. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use cash-secured put on CNTB
Cash-secured puts on CNTB earn premium while a trader waits to acquire CNTB stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning CNTB.
CNTB thesis for this cash-secured put
The market-implied 1-standard-deviation range for CNTB extends from approximately $0.91 on the downside to $4.23 on the upside. A CNTB cash-secured put lets a trader earn premium while waiting to acquire CNTB at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current CNTB IV rank near 68.54% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on CNTB should anchor more to the directional view and the expected-move geometry. As a Healthcare name, CNTB options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CNTB-specific events.
CNTB cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CNTB positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CNTB alongside the broader basket even when CNTB-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on CNTB carry tail risk when realized volatility exceeds the implied move; review historical CNTB earnings reactions and macro stress periods before sizing. Always rebuild the position from current CNTB chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on CNTB?
- A cash-secured put on CNTB is the cash-secured put strategy applied to CNTB (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With CNTB stock at $2.57 on the most recent close, the strikes shown on this page are snapped to the nearest listed CNTB chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are CNTB cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the CNTB cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 225.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CNTB cash-secured put?
- The breakeven for the CNTB cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CNTB market-implied 1-standard-deviation expected move in the same options snapshot is approximately 64.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on CNTB?
- Cash-secured puts on CNTB earn premium while a trader waits to acquire CNTB stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning CNTB.
- How does current CNTB implied volatility affect this cash-secured put?
- CNTB ATM IV is at 225.00% with IV rank near 68.54%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.